| Opportunity ID: | 334708 | | Opportunity Number: | RFA-PS-22-001 | | Opportunity Title: | Implementing Pre-exposure Prophylaxis for HIV Prevention in Syringe Service Programs | | Opportunity Category: | Discretionary | | Opportunity Category Explanation: | | | Funding Instrument Type: | Cooperative Agreement | | Category of Funding Activity: | Health | | Category Explanation: | | | CFDA Number(s): | 93.084 | | Eligible Applicants: | State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification) | | Additional Information on Eligibility: | The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits (Other than Institutions of Higher Education) Eligible Agencies of the Federal Government U.S. Territory or Possession Faith-based or Community-based Organizations Regional Organizations Bona Fide Agents: a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via https://www.grants.gov Federally Funded Research and Development Centers (FFRDCs): FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not-for-profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long-term research or development need which cannot be met as effectively by an agency's existing in-house or contractor resources. FFRDC's enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to https://ecfr.io or https://www.nsf.gov/statistics/ffrdclist/ Foreign Organizations: a Foreign Organization is a public or private organization, whether non-profit or for-profit, located in a country other than the United States (U.S.) and its territories that is subject to the laws of the country in which it is located, irrespective of the citizenship of the project staff or place of performance. Foreign components of U.S. Organizations. For this announcement, applicants may include collaborators or consultants from foreign institutions. | | Agency Code: | HHS-CDC-HHSCDCERA | | Agency Name: | Department of Health and Human Services
Centers for Disease Control and Prevention – ERA | | Posted Date: | Jul 13, 2021 | | Last Updated Date: | Jul 13, 2021 | | Estimated Synopsis Post Date: | Jan 11, 2022 | | Fiscal Year: | 2022 | | Award Ceiling: | $625,000 | | Award Floor: | $500,000 | | Estimated Total Program Funding: | $2,500,000 | | Expected Number of Awards: | 1 | | Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to support implementation research on combining HIV prevention modalities to add navigation for HIV pre-exposure prophylaxis (PrEP) at syringe service programs (SSPs) for people who inject drugs (PWID). The recipient should be an organization or institution that includes or partners with multiple and diverse SSPs. CDC is interested in increasing PrEP care through SSPs by incorporating more PrEP navigation and support into standard processes. The NOFO seeks effectiveness-implementation research on the acceptability and feasibility of a navigator-enhanced PWID PrEP service bundle at SSPs and optimizing it for initiation and retention in PrEP care among adult PWID. Applied research resulting from this funding is expected to strengthen combined HIV prevention for PWID and is aligned with the HIV National Strategic Plan (2021-2025) and the Ending the HIV Epidemic in the U.S. (EHE) initiative “Prevent” Pillar. | | Version: | 1 |
|
